chr7-100720818-CCACCGCGCCCGCTCTGCTCCGA-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_000799.4(EPO):c.-152_-131del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00331 in 822,298 control chromosomes in the GnomAD database, including 46 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.012 ( 31 hom., cov: 31)
Exomes 𝑓: 0.0014 ( 15 hom. )
Consequence
EPO
NM_000799.4 5_prime_UTR
NM_000799.4 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.40
Genes affected
EPO (HGNC:3415): (erythropoietin) This gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The encoded protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow. Expression of this gene is upregulated under hypoxic conditions, in turn leading to increased erythropoiesis and enhanced oxygen-carrying capacity of the blood. Expression of this gene has also been observed in brain and in the eye, and elevated expression levels have been observed in diabetic retinopathy and ocular hypertension. Recombinant forms of the encoded protein exhibit neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types, and have been used in the treatment of anemia and to enhance the efficacy of cancer therapies. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 7-100720818-CCACCGCGCCCGCTCTGCTCCGA-C is Benign according to our data. Variant chr7-100720818-CCACCGCGCCCGCTCTGCTCCGA-C is described in ClinVar as [Likely_benign]. Clinvar id is 3056168.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0118 (1801/152226) while in subpopulation AFR AF= 0.04 (1662/41550). AF 95% confidence interval is 0.0384. There are 31 homozygotes in gnomad4. There are 843 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 31 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EPO | NM_000799.4 | c.-152_-131del | 5_prime_UTR_variant | 1/5 | ENST00000252723.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EPO | ENST00000252723.3 | c.-152_-131del | 5_prime_UTR_variant | 1/5 | 1 | NM_000799.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0118 AC: 1794AN: 152118Hom.: 31 Cov.: 31
GnomAD3 genomes
AF:
AC:
1794
AN:
152118
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00137 AC: 917AN: 670072Hom.: 15 AF XY: 0.00123 AC XY: 408AN XY: 331080
GnomAD4 exome
AF:
AC:
917
AN:
670072
Hom.:
AF XY:
AC XY:
408
AN XY:
331080
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0118 AC: 1801AN: 152226Hom.: 31 Cov.: 31 AF XY: 0.0113 AC XY: 843AN XY: 74412
GnomAD4 genome
AF:
AC:
1801
AN:
152226
Hom.:
Cov.:
31
AF XY:
AC XY:
843
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3462
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
EPO-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 01, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at